Advances in therapeutic targeting of the DNA damage response in cancer.

about

Scorpins in the DNA Damage Response.Induction of Oxidative DNA Damage in Bovine Herpesvirus 1 Infected Bovine Kidney Cells (MDBK Cells) and Human Tumor Cells (A549 Cells and U2OS Cells)

P2860

Q55608144-21611448-636A-4F36-8278-C5C830E07DAA Q56561196-4DD6E404-867F-4BAE-9585-B9E0D5403A78

P2860

Advances in therapeutic targeting of the DNA damage response in cancer.

Item

http://www.wikidata.org/entity/Q55306606

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Advances in therapeutic targeting of the DNA damage response in cancer.

@en

Advances in therapeutic targeting of the DNA damage response in cancer.

@nl

type

Item

label

Advances in therapeutic targeting of the DNA damage response in cancer.

@en

Advances in therapeutic targeting of the DNA damage response in cancer.

@nl

prefLabel

Advances in therapeutic targeting of the DNA damage response in cancer.

@en

Advances in therapeutic targeting of the DNA damage response in cancer.

@nl

P1476

Advances in therapeutic targeting of the DNA damage response in cancer.

@en

P2093

Amar Desai

http://www.w3.org/2001/XMLSchema#string

Stanton L Gerson

http://www.w3.org/2001/XMLSchema#string

Yan Yan

http://www.w3.org/2001/XMLSchema#string

P2860

DNA repair targeted therapy: The past or future of cancer treatment?

Sources of DNA double-strand breaks and models of recombinational DNA repair

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Base excision repair

Roles of Chk1 in cell biology and cancer therapy

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer

Caffeine inhibits the checkpoint kinase ATM

Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction

P304

24-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DNAREP.2018.04.004

http://www.w3.org/2001/XMLSchema#string

P478

66-67

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29715575

http://www.w3.org/2001/XMLSchema#string

P932

6005187

http://www.w3.org/2001/XMLSchema#string

Advances in therapeutic targeting of the DNA damage response in cancer.

about

P2860

P2860

Advances in therapeutic targeting of the DNA damage response in cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932